Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) shares crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $55.35 and traded as low as $54.95. Lonza Group shares last traded at $55.15, with a volume of 48,975 shares traded.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft raised Lonza Group from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd.
Read Our Latest Report on Lonza Group
Lonza Group Stock Down 0.9 %
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.
Featured Stories
- Five stocks we like better than Lonza Group
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Comprehensive Analysis of PayPal Stock
- How to Evaluate a Stock Before Buying
- Intuitive Surgical Stock Can Trend Much Higher This Year
- How Investors Can Find the Best Cheap Dividend Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.